DRX CHOICE

Serial Number 88314307
Registration 5872019
700

Registration Progress

Application Filed
Feb 25, 2019
Under Examination
Approved for Publication
Jul 16, 2019
Published for Opposition
Jul 16, 2019
Registered
Oct 1, 2019

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2019-10-01)
Due: Oct 01, 2025 85 days

Basic Information

Serial Number
88314307
Registration Number
5872019
Deadline
October 1, 2025
Description
5 Year - Section 8 and 15 Renewal
Filing Date
February 25, 2019
Registration Date
October 1, 2019
Published for Opposition
July 16, 2019
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Oct 1, 2019
Registration
Registered
Classes
005

Rights Holder

Raritan Pharmaceuticals

03
Address
6810 Lyons Technology Pkwy, Suite 140
Coconut Creek, FL 33073

Ownership History

Raritan Pharmaceuticals

Original Applicant
03
East Brunswick, NJ

Raritan Pharmaceuticals

Owner at Publication
03
East Brunswick, NJ

Raritan Pharmaceuticals

Original Registrant
03
Coconut Creek, FL

Legal Representation

Attorney
Nicole K. McLaughlin, Esquire

USPTO Deadlines

Next Deadline
85 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2019-10-01)
Due Date
October 01, 2025
Grace Period Ends
April 01, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

22 events
Date Code Type Description
Oct 1, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Sep 21, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 21, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 21, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 21, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 21, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 1, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER
Jul 16, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 16, 2019 PUBO A PUBLISHED FOR OPPOSITION
Jun 26, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 13, 2019 ALIE A ASSIGNED TO LIE
May 30, 2019 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
May 22, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
May 21, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
May 21, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 7, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 7, 2019 GNRT F NON-FINAL ACTION E-MAILED
May 7, 2019 CNRT R NON-FINAL ACTION WRITTEN
May 6, 2019 DOCK D ASSIGNED TO EXAMINER
Mar 21, 2019 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 15, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 28, 2019 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Over-the-counter pharmaceuticals, namely, pharmaceutical preparations for cough and cold, pain, lowering cholesterol, laxation, diarrhea, fiber therapy, digestion; nutritional supplements
First Use Anywhere: 20050000
First Use in Commerce: 20050000

Additional Information

Design Mark
The mark consists of stylized "DRx" with a line leading from "Rx" and which underlines "CHOICE".
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"DR" AND "RX"